Drug therapy in the elderly
- PMID: 14577060
- DOI: 10.1016/s0026-0495(03)00298-1
Drug therapy in the elderly
Abstract
This review examines altered drug responses during aging. The incidence of diseases and disorders that require drug treatment rapidly increases with advancing age; elderly patients tend to receive more medications more often and are therefore at a correspondingly higher risk of experiencing adverse drug reactions and interactions. The cognitive decline that commonly accompanies aging can exacerbate this problem, with elderly individuals becoming confused and forgetful about their prescribed medications. Physiological responses to drugs depend on several factors, including the time course of drug absorption, distribution, metabolism, and elimination in the body (pharmacokinetics), and the actions of these drugs at the intracellular level (pharmacodynamics). As people age, the pathophysiologic processes of aging will influence all of these factors, including the time course of drug concentration in the body and target organ sensitivity. These age-related pharmacokinetic and pharmacodynamic effects must always be kept in mind by those responsible for the medical care of the elderly.
Similar articles
-
Drug therapy in the elderly.South Med J. 1992 Feb;85(2):127-31. doi: 10.1097/00007611-199202000-00004. South Med J. 1992. PMID: 1738877 Review.
-
Drug dosage in the elderly. Is it rational?Drugs Aging. 1998 Nov;13(5):357-79. doi: 10.2165/00002512-199813050-00003. Drugs Aging. 1998. PMID: 9829164 Review.
-
Pharmacokinetic-pharmacodynamic crisis in the elderly.Am J Ther. 2007 Sep-Oct;14(5):488-98. doi: 10.1097/01.mjt.0000183719.84390.4d. Am J Ther. 2007. PMID: 17890940 Review.
-
Pharmacokinetic and pharmacodynamic alterations in the geriatric patient.Consult Pharm. 2008 Apr;23(4):324-34. doi: 10.4140/tcp.n.2008.324. Consult Pharm. 2008. PMID: 18454589
-
Predicting and preventing adverse drug reactions in the very old.Drugs Aging. 2005;22(5):375-92. doi: 10.2165/00002512-200522050-00003. Drugs Aging. 2005. PMID: 15903351 Review.
Cited by
-
Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects.Clin Pharmacokinet. 2008;47(1):47-59. doi: 10.2165/00003088-200847010-00005. Clin Pharmacokinet. 2008. PMID: 18076218 Clinical Trial.
-
Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study.Drugs Aging. 2013 Apr;30(4):235-46. doi: 10.1007/s40266-013-0057-0. Drugs Aging. 2013. PMID: 23408163 Clinical Trial.
-
Indication for pharmacological treatment is often lacking: a cross-sectional study on the quality of drug therapy among the elderly.BMC Geriatr. 2015 Oct 8;15:117. doi: 10.1186/s12877-015-0117-x. BMC Geriatr. 2015. PMID: 26449212 Free PMC article.
-
Oral anticoagulants in older adults with atrial fibrillation.J Thromb Thrombolysis. 2013 Nov;36(4):403-15. doi: 10.1007/s11239-013-0869-0. J Thromb Thrombolysis. 2013. PMID: 23341180 Free PMC article. Review.
-
Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis.Clin Pharmacokinet. 2006;45(3):287-95. doi: 10.2165/00003088-200645030-00004. Clin Pharmacokinet. 2006. PMID: 16509760
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials